Skip to main content
Market intelligence
TWSTHealthcare

Twist Bioscience Corp insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 10, 2026Emily M. LeproustChief Executive OfficerSale113,318$125.16$14,183,051
Aug 7, 2026Robert ChessDirectorSale18,417$110.89$2,042,261
Aug 5, 2026Dennis ChoSee RemarksSale14,205$109.75$1,558,999